Fcγ receptors as regulators of immune responses
The DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
In addition to their role in binding antigen, antibodies can regulate immune responses through interacting with Fc receptors (FcRs). In recent years, significant progress has been made in understanding the mechanisms that regulate the activity of IgG antibodies in vivo. In this Review, we discuss recent studies addressing the multifaceted roles of FcRs for IgG (FcgammaRs) in the immune system and how this knowledge could be translated into novel therapeutic strategies to treat human autoimmune, infectious or malignant diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FcγR activation induces macrophage phagocytosis.44”
From Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling (2023) · cites this paper as [44]
Citations
Cites
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Self-citationShields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754 · cited 1×
“Evidence that this sugar residue is involved in immune regulatory processes was obtained by studying the mechanism of the anti-inflammatory activity of IVIG therap”
BackgroundSelf-citationDifferential Antigen Processing by Dendritic Cell Subsets in Vivo
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.-W., Park, C. G., et al. (2007) · Science · doi:10.1126/science.1136080 · Cited by 1,455
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,307 · cited 1×
“This sugar side chain consists of a conserved biantennary heptasaccharide core structure containing mannose and N-acetylglucosamine (GlcNac) with varying additions of terminal and branching residues such as fucose, GlcNac, galactose and sialic aci”
BackgroundWeng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300 · cited 1×
“Several studies of lymphoma patients who had received Rituximab, a B-cell depleting chimeric IgG1 antibody that is specific for CD20, revealed that those patients with activating FcγR alleles that had a higher binding affinity for the Fc fragment of the therapeutic antibody displayed significantly improved clinical re…”
Background
Cited by
Items 101–200 of 1,008
Mechanisms of action of CD20 antibodies.
Boross, P., & Leusen, J. H. W. (2012) · PubMed · Cited by 252
Fc receptors in antibody‐dependent enhancement of viral infections
Taylor, A., Foo, S., Bruzzone, R., Vu Dinh, L., King, N. J. C., & Mahalingam, S. (2015) · Immunological Reviews · doi:10.1111/imr.12367 · Cited by 255
Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies
Brennan, F. R., Morton, L. D., Spindeldreher, S., Kiessling, A., Allenspach, R., Hey, A., Müller, P., Frings, W., & Sims, J. (2010) · mAbs · doi:10.4161/mabs.2.3.11782 · Cited by 250
“The cellular expression and function of FcγRs has recently been reviewed.(47) IgG 1 (and IgG 3 ) bind all FcγRs and fix complement and thus have the greatest potential for Fc-mediated effector function (Table 3).”
BackgroundNordstrom, J. L., Gorlatov, S., Zhang, W., Yang, Y., Huang, L., Burke, S., Li, H., Ciccarone, V., Zhang, T., Stavenhagen, J., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr3069 · Cited by 250
“Murine CD16 is a low-affinity activating FcgR that is approximately 60% homologous to human CD32A but that, similarly to human CD16A, is distributed on murine NK cells and mononuclear phagocytes [22].”
Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
Yip, M. S., Leung, N. H. L., Cheung, C. Y., Li, P. H., Lee, H. H. Y., Daëron, M., Peiris, J. S. M., Bruzzone, R., & Jaume, M. (2014) · Virology Journal · doi:10.1186/1743-422x-11-82 · Cited by 250
“Although it would have been desirable to perform FcγR blocking experiments also in macrophages, coexpression of all FcγRs in these cells [29, 30] However, the relationship between internalization of immune complexes and ADE of infection by SARS-CoV via FcγRIIs appears to be a complex process.”
BackgroundAnti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis
Castro-Dopico, T., Dennison, T. W., Ferdinand, J. R., Mathews, R. J., Fleming, A., Clift, D., Stewart, B. J., Jing, C., Strongili, K., Labzin, L. I., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.02.006 · Cited by 248
“In vitro, IgG IC stimulation of BMDM from mice with a low FcgR A:I ratio due to macrophage-specific overexpression of FcgRIIB (Brownlie et al., 2008) (macrophagetransgenic [M-TG]) resulted in lower Il1b induction than in BMDM from WT mice, in contrast to BMDM from mice with a high A:I ratio due to FcgRIIB deficiency,…”
BackgroundInfluentialChemoenzymatic Methods for the Synthesis of Glycoproteins
Li, C., & Wang, L.-X. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00238 · Cited by 250
Wilson, N. S., Yang, B., Yang, A., Loeser, S., Marsters, S., Lawrence, D., Li, Y., Pitti, R., Totpal, K., Yee, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.012 · Cited by 248
“It remains possible nonetheless that in some tumor types ADCCmay also contribute to drozitumab’s antitumor activity.”
BackgroundInfluentialForthal, D. N. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.aid-0019-2014 · Cited by 231
Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
Liu, R., Oldham, R., Teal, E., Beers, S., & Cragg, M. (2020) · Antibodies · doi:10.3390/antib9040064 · Cited by 238
Obligatory Role for B Cells in the Development of Angiotensin II–Dependent Hypertension
Chan, C. T., Sobey, C. G., Lieu, M., Ferens, D., Kett, M. M., Diep, H., Kim, H. A., Krishnan, S. M., Lewis, C. V., Salimova, E., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05779 · Cited by 243
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses
Descours, B., Petitjean, G., López-Zaragoza, J.-L., Bruel, T., Raffel, R., Psomas, C., Reynes, J., Lacabaratz, C., Levy, Y., Schwartz, O., et al. (2017) · Nature · doi:10.1038/nature21710 · Cited by 242
Tackenberg, B., Jelčić, I., Baerenwaldt, A., Oertel, W. H., Sommer, N., Nimmerjahn, F., & Lünemann, J. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807319106 · Cited by 242
Self-citationThe role of calcium signaling in phagocytosis
Nunes, P., & Demaurex, N. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0110028 · Cited by 242
“Finally, cell-specific expression of FcR subtypes may change depending on extrinsic factors: hFc RI expression can be induced in neutrophils by IFN- and G-CSF [26–28], whereas IFN- induces hFc RIIIA expression and hFc RI up-regulation in monocytes [20, 27].”
BackgroundInfluentialSeidel, U. J. E., Schlegel, P., & Lang, P. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00076 · Cited by 236
“Most hematopoietic cells, except most T cell subsets, express Fcγ receptors (FcγRs) (Nimmerjahn and Ravetch, 2008).”
BackgroundMolecular mechanisms and therapeutic target of NETosis in diseases
Huang, J., Hong, W., Wan, M., & Zheng, L. (2022) · MedComm · doi:10.1002/mco2.162 · Cited by 226
Golay, J., Da Roit, F., Bologna, L., Ferrara, C., Leusen, J. H., Rambaldi, A., Klein, C., & Introna, M. (2013) · Blood · doi:10.1182/blood-2013-05-504043 · Cited by 235
Chang, B. Y., Huang, M. M., Francesco, M., Chen, J., Sokolove, J., Magadala, P., Robinson, W. H., & Buggy, J. J. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3400 · Cited by 231
“During the chronic inflammatory phase of the disease, autoantibodies, and immune complexes (ICs) further activate sentinel and effector cells such as neutrophils, monocytes/macrophages, dendritic cells, and mast cells that infiltrate the synovium and release proinflammatory cytokines and matrix metalloproteases, leadi…”
BackgroundResultInfluentialN-glycomic biomarkers of biological aging and longevity: A link with inflammaging
Dall’Olio, F., Vanhooren, V., Chen, C. C., Slagboom, P. E., Wuhrer, M., & Franceschi, C. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.02.002 · Cited by 231
“…ith a variety of hematological and immunological disorders the so called intravenous IgG, IVIG) results in a suppression of he immune response (Nimmerjahn and Ravetch, 2007, 2008a). lthough this phenomenon has already for a long time been xploited in the clinical practice, its mechanism of…”
BackgroundHart, A. D., Wyttenbach, A., Hugh Perry, V., & Teeling, J. L. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.11.006 · Cited by 230
“Fc c Rs bind IgG, and play a role in antigen presentation and uptake of opsonised cell debris (Nimmerjahn and Ravetch, 2008).”
Meningococcal disease and the complement system
Lewis, L. A., & Ram, S. (2014) · Virulence · doi:10.4161/viru.26515 · Cited by 227
Selby, M. J., Engelhardt, J. J., Johnston, R. J., Lu, L.-S., Han, M., Thudium, K., Yao, D., Quigley, M., Valle, J., Wang, C., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161779 · Cited by 231
Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
Tay, M. Z., Wiehe, K., & Pollara, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00332 · Cited by 229
“The released virus PAMPs can prime an inflammatory response upon sensing by PRRs, which may then stimulate additional immune cells and activate subsequent immune responses (12, 13) .”
BackgroundInfluentialWiernik, A., Foley, B., Zhang, B., Verneris, M. R., Warlick, E., Gleason, M. K., Ross, J. A., Luo, X., Weisdorf, D. J., Walcheck, B., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0505 · Cited by 226
Mosconi, E., Rekima, A., Seitz-Polski, B., Kanda, A., Fleury, S., Tissandie, E., Monteiro, R., Dombrowicz, D. D., Julia, V, Glaichenhaus, N., et al. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.23 · Cited by 227
Crosstalk between Human IgG Isotypes and Murine Effector Cells
Overdijk, M. B., Verploegen, S., Ortiz Buijsse, A., Vink, T., Leusen, J. H. W., Bleeker, W. K., & Parren, P. W. H. I. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200356 · Cited by 229
Ackerman, S. E., Pearson, C. I., Gregorio, J. D., Gonzalez, J. C., Kenkel, J. A., Hartmann, F. J., Luo, A., Ho, P. Y., LeBlanc, H., Blum, L. K., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00136-x · Cited by 213
The influence of ACPA status and characteristics on the course of RA
Willemze, A., Trouw, L. A., Toes, R. E. M., & Huizinga, T. W. J. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.204 · Cited by 221
Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation
Junker, F., Gordon, J., & Qureshi, O. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01393 · Cited by 219
The Structural Role of Antibody N-Glycosylation in Receptor Interactions
Subedi, G. P., & Barb, A. W. (2015) · Structure · doi:10.1016/j.str.2015.06.015 · Cited by 216
“These protective and curative effects largely require an intact IgG fragment crystallizable (Fc) region for appropriate interaction with cell surface Fc g receptors (FcgRs) (Bruhns et al., 2009; Jiang et al., 2011; Nimmerjahn and Ravetch, 2008; Siberil et al., 2007).”
BackgroundNatural killer cell cytotoxicity and its regulation by inhibitory receptors
Kumar, S. (2018) · Immunology · doi:10.1111/imm.12921 · Cited by 216
A comprehensive atlas of immunological differences between humans, mice, and non-human primates
Bjornson-Hooper, Z. B., Fragiadakis, G. K., Spitzer, M. H., Chen, H., Madhireddy, D., Hu, K., Lundsten, K., McIlwain, D. R., & Nolan, G. P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867015 · Cited by 215
Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis
Jing, C., Castro-Dopico, T., Richoz, N., Tuong, Z. K., Ferdinand, J. R., Lok, L. S. C., Loudon, K. W., Banham, G. D., Mathews, R. J., Cader, Z., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000943117 · Cited by 216
Targeted Intracellular Delivery of Antibodies: The State of the Art
Slastnikova, T. A., Ulasov, A. V., Rosenkranz, A. A., & Sobolev, A. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01208 · Cited by 215
“The intracellular localization of antibodies and their complexes with antigens that enter the cell by antibody-driven mechanisms [e.g., via several types of Fc-receptors (Nimmerjahn and Ravetch, 2008)] is initially normally limited to endocytic vesicles, such as endosomes or phagosomes.”
BackgroundBruton Tyrosine Kinase (BTK) and Its Role in B-cell Malignancy
Buggy, J. J., & Elias, L. (2012) · International Reviews of Immunology · doi:10.3109/08830185.2012.664797 · Cited by 211
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Zhang, A., Stacey, H. D., D’Agostino, M. R., Tugg, Y., Marzok, A., & Miller, M. S. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00813-1 · Cited by 214
New immune cell engagers for cancer immunotherapy
Fenis, A., Demaria, O., Gauthier, L., Vivier, E., & Narni-Mancinelli, E. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00982-7 · Cited by 203
“These artificially produced IgGA antibodies not only bind to human CD89 with similar affinity to IgA antibodies, but also bind to human CD64, CD32A, CD32B and C1q with similar affinity to IgG1 antibodies.”
InfluentialAggregation of Protein Therapeutics Enhances Their Immunogenicity: Causes and Mitigation Strategies
Lundahl, M. L. E., Fogli, S., Colavita, P. E., & Scanlan, E. M. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00067e · Cited by 212
Murin, C. D., Wilson, I. A., & Ward, A. B. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0392-y · Cited by 213
Identity of the elusive IgM Fc receptor (FcμR) in humans
Kubagawa, H., Oka, S., Kubagawa, Y., Torii, I., Takayama, E., Kang, D.-W., Gartland, G. L., Bertoli, L. F., Mori, H., Takatsu, H., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091107 · Cited by 209
“…both B and T lymphocytes, is remarkable, because FcRs for the switched Ig isotypes (Fc Rs, Fc RI, and Fc R) are expressed by various hematopoietic cells, including phagocytes, and are thought to be central mediators coupling the innate and adaptive immune responses ( Nimmerjahn and Ravetch, 2008 ).”
BackgroundFc Glycan-Mediated Regulation of Placental Antibody Transfer
Jennewein, M. F., Goldfarb, I., Dolatshahi, S., Cosgrove, C., Noelette, F. J., Krykbaeva, M., Das, J., Sarkar, A., Gorman, M. J., Fischinger, S., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.044 · Cited by 212
“…Cell 178, 202–215, June 27, 2019 extracellular region of the activating FCGR2A and the inhibitory FCGR2B (Nimmerjahn and Ravetch, 2006), FCGR2B-driven sieving would result in enhanced transfer of antibodies with ADCP activity, which is largely mediated through FCGR2A (Nimmerjahn and Ravetch, 2008).”
BackgroundInfluentialMechanisms of Immune Complex–Mediated Neutrophil Recruitment and Tissue Injury
Mayadas, T. N., Tsokos, G. C., & Tsuboi, N. (2009) · Circulation · doi:10.1161/circulationaha.108.771170 · Cited by 208
IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy
Kanagaratham, C., El Ansari, Y. S., Lewis, O. L., & Oettgen, H. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603050 · Cited by 205
Wilk, A. J., Lee, M. J., Wei, B., Parks, B., Pi, R., Martínez-Colón, G. J., Ranganath, T., Zhao, N. Q., Taylor, S., Becker, W., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20210582 · Cited by 217
“…using Seurat ’ s implementation of the Wilcoxon rank-sum test (FindMarkers()) and comparing those markers with known cell type – specific genes from previous datasets (Gutierrez-Arcelus et al., 2019; Villani et al., 2017; Kang et al., 2018; Nimmerjahn and Ravetch, 2008, 2006; Palmer et al., 2006).”
Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype
Dowd, K. A., DeMaso, C. R., Pelc, R. S., Speer, S. D., Smith, A. R. Y., Goo, L., Platt, D. J., Mascola, J. R., Graham, B. S., Mulligan, M. J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.049 · Cited by 206
“The antiviral activity of convalescent and vaccine-induced antibodies reflects their capacity to bind to and neutralize virion infectivity, as well as mediate other effector functions (Burton, 2002; Nimmerjahn and Ravetch, 2008).”
Bruton tyrosine kinase inhibitors for multiple sclerosis
Krämer, J., Bar-Or, A., Turner, T. J., & Wiendl, H. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00800-7 · Cited by 206
Ha, D., Tanaka, A., Kibayashi, T., Tanemura, A., Sugiyama, D., Wing, J. B., Lim, E. L., Teng, K. W. W., Adeegbe, D., Newell, E. W., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812186116 · Cited by 205
FcγR Binding and ADCC Activity of Human IgG Allotypes
de Taeye, S. W., Bentlage, A. E. H., Mebius, M. M., Meesters, J. I., Lissenberg-Thunnissen, S., Falck, D., Sénard, T., Salehi, N., Wuhrer, M., Schuurman, J., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00740 · Cited by 206
“These bind the pathogen via their Fab domains and subsequently activate both complement but also immune cells by immunoglobulin Fc-receptors (1).”
BackgroundYu, M., Brown, D., Reed, C., Chung, S., Lutman, J., Stefanich, E., Wong, A., Stephan, J.-P., & Bayer, R. (2012) · mAbs · doi:10.4161/mabs.20737 · Cited by 203
Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease
Pagan, J. D., Kitaoka, M., & Anthony, R. M. (2018) · Cell · doi:10.1016/j.cell.2017.11.041 · Cited by 204
“They are essential for clearance of microbes by bridging the adaptive and innate immune systems, but they can also contribute to the pathogenesis of autoimmune diseases when they are generated against self (Nimmerjahn and Ravetch, 2008b).”
Effects of Bovine Immunoglobulins on Immune Function, Allergy, and Infection
Ulfman, L. H., Leusen, J. H. W., Savelkoul, H. F. J., Warner, J. O., & van Neerven, R. J. J. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00052 · Cited by 199
B Cells in Autoimmune Diseases
Hampe, C. S. (2012) · Scientifica · doi:10.6064/2012/215308 · Cited by 202
FERRARI, S., MUDDE, G. C., RIEGER, M., VEYRADIER, A., KREMER HOVINGA, J. A., & SCHEIFLINGER, F. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03568.x · Cited by 200
B cells and antibodies in the defense against Mycobacterium tuberculosis infection
Achkar, J. M., Chan, J., & Casadevall, A. (2015) · Immunological Reviews · doi:10.1111/imr.12276 · Cited by 200
Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages
Stamatiades, E. G., Tremblay, M.-E., Bohm, M., Crozet, L., Bisht, K., Kao, D., Coelho, C., Fan, X., Yewdell, W. T., Davidson, A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.058 · Cited by 199
“…portion of immunoglobulin G (FcγRs) are protected from acute and progressive glomerulonephritis, arthritis, SLE nephritis, and the Arthus reaction (Nimmerjahn and Ravetch, 2008), suggesting that activating FcγRs expressed by cells of the innate immune system play a major role in type III…”
Self-citationLong-lasting antitumor protection by anti-CD20 antibody through cellular immune response
Abès, R., Gélizé, E., Fridman, W. H., & Teillaud, J.-L. (2010) · Blood · doi:10.1182/blood-2009-10-248609 · Cited by 198
FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo
Nimmerjahn, F., Lux, A., Albert, H., Woigk, M., Lehmann, C., Dudziak, D., Smith, P., & Ravetch, J. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014515107 · Cited by 200
Self-citationRole of Dendritic Cells in Antibody-Dependent Enhancement of Dengue Virus Infection
Boonnak, K., Slike, B. M., Burgess, T. H., Mason, R. M., Wu, S.-J., Sun, P., Porter, K., Rudiman, I. F., Yuwono, D., Puthavathana, P., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02484-07 · Cited by 191
“Our study examined the role of two different forms of FcRII expressed on DC in ADE: the activating (FcRIIa) and inhibitory (FcRIIb) isoforms (Fig. 5A and B). We and others (4, 28, 41) reported that the ratio of FcRIIa to FcRIIb is increased in matDC and propose that these changes regulate DC function and control cellu…”
BackgroundAntimicrobial Mechanisms of Macrophages and the Immune Evasion Strategies of Staphylococcus aureus
Flannagan, R., Heit, B., & Heinrichs, D. (2015) · Pathogens · doi:10.3390/pathogens4040826 · Cited by 193
“immunoglobulins [227], the pentraxin proteins [228,229], and the complement system [226,230].”
BackgroundGunderson, A. J., Rajamanickam, V., Bui, C., Bernard, B., Pucilowska, J., Ballesteros-Merino, C., Schmidt, M., McCarty, K., Philips, M., Piening, B., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1900635 · Cited by 197
The tipping points in the initiation of B cell signalling: how small changes make big differences
Pierce, S. K., & Liu, W. (2010) · Nature Reviews Immunology · doi:10.1038/nri2853 · Cited by 192
“FcγRIIB expressed by B cells is a potent inhibitor of BCR signallin”
Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease
Pandey, M. K., Burrow, T. A., Rani, R., Martin, L. J., Witte, D., Setchell, K. D., Mckay, M. A., Magnusen, A. F., Zhang, W., Liou, B., et al. (2017) · Nature · doi:10.1038/nature21368 · Cited by 194
Fc fusion as a platform technology: potential for modulating immunogenicity
Levin, D., Golding, B., Strome, S. E., & Sauna, Z. E. (2015) · Trends in Biotechnology · doi:10.1016/j.tibtech.2014.11.001 · Cited by 195
Liu, Z., Xu, W., Xia, S., Gu, C., Wang, X., Wang, Q., Zhou, J., Wu, Y., Cai, X., Qu, D., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00402-5 · Cited by 200
Keating, R., Hertz, T., Wehenkel, M., Harris, T. L., Edwards, B. A., McClaren, J. L., Brown, S. A., Surman, S., Wilson, Z. S., Bradley, P., et al. (2013) · Nature Immunology · doi:10.1038/ni.2741 · Cited by 193
Extracellular targeted protein degradation: an emerging modality for drug discovery
Wells, J. A., & Kumru, K. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00833-z · Cited by 176
“Third, antibodies bound to a cell-surface target can recruit natural killer (NK) cells, macrophages and the complement system to kill cells via effector functions such as antibody-directed cellular cytotoxicity 112,113 or complement-dependent cytotoxicity.”
Landscape of B cell immunity and related immune evasion in human cancers
Hu, X., Zhang, J., Wang, J., Fu, J., Li, T., Zheng, X., Wang, B., Gu, S., Jiang, P., Fan, J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0339-x · Cited by 191
Expression, Role, and Regulation of Neutrophil Fcγ Receptors
Wang, Y., & Jönsson, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01958 · Cited by 188
T Lymphocytes Expressing a CD16 Signaling Receptor Exert Antibody-Dependent Cancer Cell Killing
Kudo, K., Imai, C., Lorenzini, P., Kamiya, T., Kono, K., Davidoff, A. M., Chng, W. J., & Campana, D. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1365 · Cited by 191
Novel roles for the IgG Fc glycan
Anthony, R. M., Wermeling, F., & Ravetch, J. V. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06305.x · Cited by 186
Self-citationCancer and Innate Immune System Interactions: Translational Potentials for Cancer Immunotherapy
Liu, Y., & Zeng, G. (2012) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182518e83 · Cited by 185
Mechanisms of disease: The human N-glycome
Lauc, G., Pezer, M., Rudan, I., & Campbell, H. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.10.016 · Cited by 184
Antibody-mediated neutralization of flaviviruses: A reductionist view
Dowd, K. A., & Pierson, T. C. (2011) · Virology · doi:10.1016/j.virol.2010.12.020 · Cited by 186
“Antibodies exert their antiviral effects by virtue of a capacity to bind viruses and directly neutralize infectivity, as well as via effector functions coordinated by the crystallizable fragment (Fc) region of the antibody heavy chain (Burton, 2002; Nimmerjahn and Ravetch, 2008).”
He, W., Tan, G. S., Mullarkey, C. E., Lee, A. J., Lam, M. M. W., Krammer, F., Henry, C., Wilson, P. C., Ashkar, A. A., Palese, P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609316113 · Cited by 182
Clearance of Fetuin-A–Containing Calciprotein Particles Is Mediated by Scavenger Receptor-A
Herrmann, M., Schäfer, C., Heiss, A., Gräber, S., Kinkeldey, A., Büscher, A., Schmitt, M. M. N., Bornemann, J., Nimmerjahn, F., Herrmann, M., et al. (2012) · Circulation Research · doi:10.1161/circresaha.111.261479 · Cited by 178
Self-citationSeeling, M., Brückner, C., & Nimmerjahn, F. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.146 · Cited by 179
Self-citationChen, X., Song, X., Li, K., & Zhang, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00292 · Cited by 174
Tsao, L.-C., Wang, J. S., Ma, X., Sodhi, S. S., Ragusa, J. V., Liu, B., McBane, J., Wang, T., Wei, J.-P., Liu, C.-X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58266-8 · Cited by 218
The role of B cells and humoral immunity in Mycobacterium tuberculosis infection
Chan, J., Mehta, S., Bharrhan, S., Chen, Y., Achkar, J. M., Casadevall, A., & Flynn, J. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.10.005 · Cited by 176
Aglycosylated immunoglobulin G1variants productively engage activating Fc receptors
Sazinsky, S. L., Ott, R. G., Silver, N. W., Tidor, B., Ravetch, J. V., & Wittrup, K. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809257105 · Cited by 177
Self-citationPros and cons of different therapeutic antibody formats for recombinant antivenom development
Laustsen, A. H., María Gutiérrez, J., Knudsen, C., Johansen, K. H., Bermúdez-Méndez, E., Cerni, F. A., Jürgensen, J. A., Ledsgaard, L., Martos-Esteban, A., Øhlenschlæger, M., et al. (2018) · Toxicon · doi:10.1016/j.toxicon.2018.03.004 · Cited by 177
Ito, H., & Hamerman, J. A. (2012) · European Journal of Immunology · doi:10.1002/eji.201141679 · Cited by 173
Albert, H., Collin, M., Dudziak, D., Ravetch, J. V., & Nimmerjahn, F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808248105 · Cited by 175
“A variety of studies have demonstrated the exclusive role of cellular receptors for the IgG constant domain (Fc receptors, Fc R) as the central mediators of autoantibody-triggered tissue inflammation (1, 2).”
BackgroundSelf-citationVogelpoel, L. T. C., Hansen, I. S., Rispens, T., Muller, F. J. M., van Capel, T. M. M., Turina, M. C., Vos, J. B., Baeten, D. L. P., Kapsenberg, M. L., de Jong, E. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms6444 · Cited by 175
Functional Characteristics of the High Affinity IgG Receptor, FcγRI
van der Poel, C. E., Spaapen, R. M., van de Winkel, J. G. J., & Leusen, J. H. W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003526 · Cited by 174
“FcgRIIB is also expressed on these cell types with the exception of NK cells.”
BackgroundInfluentialHuman IgG4: a structural perspective
Davies, A. M., & Sutton, B. J. (2015) · Immunological Reviews · doi:10.1111/imr.12349 · Cited by 170
FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities
Nimmerjahn, F., Gordan, S., & Lux, A. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.04.005 · Cited by 172
Self-citationSeeling, M., Hillenhoff, U., David, J. P., Schett, G., Tuckermann, J., Lux, A., & Nimmerjahn, F. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301001110 · Cited by 171
Self-citationGeneration of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor Cells
Felices, M., Lenvik, T. R., Davis, Z. B., Miller, J. S., & Vallera, D. A. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3684-7_28 · Cited by 170
The inflammatory function of human IgA
Hansen, I. S., Baeten, D. L. P., & den Dunnen, J. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2976-8 · Cited by 170
Venner, J. M., Hidalgo, L. G., Famulski, K. S., Chang, J., & Halloran, P. F. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13115 · Cited by 166
PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation
Mizuno, R., Sugiura, D., Shimizu, K., Maruhashi, T., Watada, M., Okazaki, I.-M., & Okazaki, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00630 · Cited by 171
Inflammatory Bowel Disease Associates with Proinflammatory Potential of the Immunoglobulin G Glycome
Trbojević Akmačić, I., Ventham, N. T., Theodoratou, E., Vučković, F., Kennedy, N. A., Krištić, J., Nimmo, E. R., Kalla, R., Drummond, H., Štambuk, J., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000372 · Cited by 166
Receptor-Mediated NETosis on Neutrophils
Chen, T., Li, Y., Sun, R., Hu, H., Liu, Y., Herrmann, M., Zhao, Y., & Muñoz, L. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.775267 · Cited by 165
Zou, G., Ochiai, H., Huang, W., Yang, Q., Li, C., & Wang, L.-X. (2011) · Journal of the American Chemical Society · doi:10.1021/ja208390n · Cited by 166
He, W., Chen, C.-J., Mullarkey, C. E., Hamilton, J. R., Wong, C. K., Leon, P. E., Uccellini, M. B., Chromikova, V., Henry, C., Hoffman, K. W., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00928-3 · Cited by 166
Bi-specific Aptamers Mediating Tumor Cell Lysis
Boltz, A., Piater, B., Toleikis, L., Guenther, R., Kolmar, H., & Hock, B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.238261 · Cited by 165
Dahan, R., Barnhart, B. C., Li, F., Yamniuk, A. P., Korman, A. J., & Ravetch, J. V. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.001 · Cited by 165
“A third class of Type I FcgRs is uniquely found in humans: a GPI-linked receptor expressed on neutrophils, FcgRIIIB, that functions to concentrate immune complexes on neutrophils (for detailed reviews see Nimmerjahn and Ravetch, 2008; Pincetic et al., 2014).”
BackgroundSelf-citationChemical and Chemoenzymatic Synthesis of Glycoproteins for Deciphering Functions
Wang, L.-X., & Amin, M. N. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.01.001 · Cited by 163
“…variety of biological recognition processes: cell adhesion, signaling, development, host-pathogen interaction, and immune response, to name a few (Dube and Bertozzi, 2005; Dwek, 1996; Haltiwanger and Lowe, 2004; Hart and Copeland, 2010; Jefferis, 2009; Nimmerjahn and Ravetch, 2008b; Varki, 1993).”
BackgroundMonoclonal antibody-induced cytokine-release syndrome
Bugelski, P. J., Achuthanandam, R., Capocasale, R. J., Treacy, G., & Bouman-Thio, E. (2009) · Expert Review of Clinical Immunology · doi:10.1586/eci.09.31 · Cited by 161
Metadata
- Authors
- Nimmerjahn, F., & Ravetch, J. V.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Rockefeller University (US)
- Venue
- Nature Reviews Immunology
- Published
- 2008-01
- Volume
- 8
- Issue
- 1
- Pages
- 34-47
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2075901113
- Cited by
- 2,947
- References
- 139
- Citations by year
- 2026: 186 · 2025: 176 · 2024: 158 · 2023: 174 · 2022: 169 · 2021: 196 · 2020: 158 · 2019: 188 · 2018: 151 · 2017: 161 · 2016: 158 · 2015: 170 · 2014: 165 · 2013: 162 · 2012: 181
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- Fc gamma receptor, IgG, antibody subclasses, immune regulation, therapeutic antibodies, autoimmune disease, infectious diseases, cancer immunotherapy, antibody effector functions
- MeSH terms
- Animals, Humans, Immunoglobulin G, Immunity, Receptors, Fc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.